Insmed Incorporated (INSM)
USD 64.97
(-4.58%)
USD 64.97
(-4.58%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -749.56 Million USD | -55.66% |
| 2022 | -481.53 Million USD | -10.79% |
| 2021 | -434.65 Million USD | -47.8% |
| 2020 | -294.09 Million USD | -15.63% |
| 2019 | -254.33 Million USD | 21.57% |
| 2018 | -324.27 Million USD | -68.33% |
| 2017 | -192.64 Million USD | -9.29% |
| 2016 | -176.27 Million USD | -49.15% |
| 2015 | -118.18 Million USD | -49.3% |
| 2014 | -79.15 Million USD | -41.17% |
| 2013 | -56.07 Million USD | -35.53% |
| 2012 | -41.37 Million USD | 30.66% |
| 2011 | -59.66 Million USD | -827.32% |
| 2010 | -6.43 Million USD | -105.44% |
| 2009 | 118.35 Million USD | 855.41% |
| 2008 | -15.66 Million USD | 21.52% |
| 2007 | -19.96 Million USD | 64.44% |
| 2006 | -56.13 Million USD | -37.16% |
| 2005 | -40.92 Million USD | -50.46% |
| 2004 | -27.2 Million USD | -164.16% |
| 2003 | -10.29 Million USD | 71.72% |
| 2002 | -36.41 Million USD | 2.02% |
| 2001 | -37.16 Million USD | 53.46% |
| 2000 | -79.86 Million USD | -924.83% |
| 1999 | -7.79 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -300.6 Million USD | -91.36% |
| 2024 Q3 | -220.52 Million USD | 26.64% |
| 2024 Q1 | -157.09 Million USD | 15.57% |
| 2023 Q4 | -186.06 Million USD | -17.07% |
| 2023 Q1 | -159.76 Million USD | 0.22% |
| 2023 Q2 | -244.8 Million USD | -53.23% |
| 2023 Q3 | -158.93 Million USD | 35.08% |
| 2023 FY | -749.56 Million USD | -55.66% |
| 2022 Q2 | -95.64 Million USD | -1.08% |
| 2022 Q4 | -160.12 Million USD | -22.1% |
| 2022 Q3 | -131.14 Million USD | -37.12% |
| 2022 FY | -481.53 Million USD | -10.79% |
| 2022 Q1 | -94.62 Million USD | 16.25% |
| 2021 Q4 | -112.97 Million USD | -0.23% |
| 2021 Q2 | -117.32 Million USD | -28.02% |
| 2021 Q1 | -91.64 Million USD | 10.34% |
| 2021 FY | -434.65 Million USD | -47.8% |
| 2021 Q3 | -112.71 Million USD | 3.93% |
| 2020 Q4 | -102.21 Million USD | -60.56% |
| 2020 Q1 | -66.36 Million USD | -25.24% |
| 2020 FY | -294.09 Million USD | -15.63% |
| 2020 Q2 | -61.85 Million USD | 6.8% |
| 2020 Q3 | -63.65 Million USD | -2.92% |
| 2019 FY | -254.33 Million USD | 21.57% |
| 2019 Q3 | -60.68 Million USD | 8.77% |
| 2019 Q4 | -52.98 Million USD | 12.68% |
| 2019 Q1 | -74.15 Million USD | 19.02% |
| 2019 Q2 | -66.51 Million USD | 10.3% |
| 2018 Q1 | -68.52 Million USD | -4.8% |
| 2018 Q4 | -91.57 Million USD | -4.37% |
| 2018 FY | -324.27 Million USD | -68.33% |
| 2018 Q2 | -76.43 Million USD | -11.55% |
| 2018 Q3 | -87.74 Million USD | -14.79% |
| 2017 FY | -192.64 Million USD | -9.29% |
| 2017 Q4 | -65.38 Million USD | -44.72% |
| 2017 Q1 | -37.41 Million USD | 45.3% |
| 2017 Q2 | -44.67 Million USD | -19.4% |
| 2017 Q3 | -45.17 Million USD | -1.13% |
| 2016 FY | -176.27 Million USD | -49.15% |
| 2016 Q4 | -68.4 Million USD | -81.15% |
| 2016 Q3 | -37.76 Million USD | -3.23% |
| 2016 Q2 | -36.57 Million USD | -9.09% |
| 2016 Q1 | -33.53 Million USD | -7.32% |
| 2015 Q3 | -30.96 Million USD | -8.23% |
| 2015 Q2 | -28.6 Million USD | -4.52% |
| 2015 Q1 | -27.36 Million USD | -55.09% |
| 2015 FY | -118.18 Million USD | -49.3% |
| 2015 Q4 | -31.24 Million USD | -0.91% |
| 2014 FY | -79.15 Million USD | -41.17% |
| 2014 Q3 | -23.99 Million USD | -3.3% |
| 2014 Q2 | -23.22 Million USD | -62.43% |
| 2014 Q1 | -14.29 Million USD | 11.82% |
| 2014 Q4 | -17.64 Million USD | 26.44% |
| 2013 Q2 | -8.85 Million USD | 35.27% |
| 2013 Q4 | -16.21 Million USD | 6.42% |
| 2013 FY | -56.07 Million USD | -35.53% |
| 2013 Q1 | -13.67 Million USD | 11.47% |
| 2013 Q3 | -17.32 Million USD | -95.7% |
| 2012 Q2 | -9.69 Million USD | -41.65% |
| 2012 Q3 | -9.38 Million USD | 3.24% |
| 2012 Q4 | -15.45 Million USD | -64.69% |
| 2012 FY | -41.37 Million USD | 30.66% |
| 2012 Q1 | -6.84 Million USD | 16.14% |
| 2011 Q1 | -6.89 Million USD | -17.97% |
| 2011 FY | -59.66 Million USD | -827.32% |
| 2011 Q2 | -10.01 Million USD | -45.3% |
| 2011 Q3 | -34.59 Million USD | -245.32% |
| 2011 Q4 | -8.16 Million USD | 76.4% |
| 2010 Q1 | 118 Thousand USD | -94.88% |
| 2010 Q2 | -378 Thousand USD | -420.34% |
| 2010 Q3 | -330 Thousand USD | 12.7% |
| 2010 Q4 | -5.84 Million USD | -1670.91% |
| 2010 FY | -6.43 Million USD | -105.44% |
| 2009 Q1 | 117.79 Million USD | 3071.62% |
| 2009 Q3 | -150 Thousand USD | 90.63% |
| 2009 Q4 | 2.3 Million USD | 1637.33% |
| 2009 FY | 118.35 Million USD | 855.41% |
| 2009 Q2 | -1.6 Million USD | -101.36% |
| 2008 Q2 | -4.66 Million USD | 4.23% |
| 2008 Q4 | -3.96 Million USD | -83.26% |
| 2008 Q1 | -4.87 Million USD | -47.8% |
| 2008 FY | -15.66 Million USD | 21.52% |
| 2008 Q3 | -2.16 Million USD | 53.65% |
| 2007 Q4 | -3.29 Million USD | 15.72% |
| 2007 Q3 | -3.91 Million USD | -56.48% |
| 2007 Q2 | -2.5 Million USD | 75.62% |
| 2007 Q1 | -10.25 Million USD | 52.15% |
| 2007 FY | -19.96 Million USD | 64.44% |
| 2006 Q3 | -12.37 Million USD | -38.84% |
| 2006 Q2 | -8.91 Million USD | 33.63% |
| 2006 Q4 | -21.42 Million USD | -73.2% |
| 2006 Q1 | -13.42 Million USD | -4.21% |
| 2006 FY | -56.13 Million USD | -37.16% |
| 2005 Q1 | -5.76 Million USD | 1.25% |
| 2005 FY | -40.92 Million USD | -50.46% |
| 2005 Q2 | -8.52 Million USD | -47.88% |
| 2005 Q3 | -13.75 Million USD | -61.38% |
| 2005 Q4 | -12.88 Million USD | 6.33% |
| 2004 Q2 | -9.01 Million USD | -89.35% |
| 2004 Q1 | -4.75 Million USD | -94.17% |
| 2004 FY | -27.2 Million USD | -164.16% |
| 2004 Q4 | -5.83 Million USD | 23.16% |
| 2004 Q3 | -7.59 Million USD | 15.7% |
| 2003 Q2 | -3.24 Million USD | -46.67% |
| 2003 FY | -10.29 Million USD | 71.72% |
| 2003 Q1 | -2.2 Million USD | 88.06% |
| 2003 Q4 | -2.45 Million USD | -2.21% |
| 2003 Q3 | -2.39 Million USD | 25.99% |
| 2002 Q3 | -4.7 Million USD | 33.78% |
| 2002 Q4 | -18.49 Million USD | -293.05% |
| 2002 Q2 | -7.1 Million USD | -16.37% |
| 2002 Q1 | -6.1 Million USD | 38.39% |
| 2002 FY | -36.41 Million USD | 2.02% |
| 2001 Q4 | -9.91 Million USD | -18.41% |
| 2001 FY | -37.16 Million USD | 53.46% |
| 2001 Q2 | -8.79 Million USD | 12.88% |
| 2001 Q1 | -10.09 Million USD | -27.76% |
| 2001 Q3 | -8.37 Million USD | 4.8% |
| 2000 Q1 | -11.3 Million USD | 0.0% |
| 2000 FY | -79.86 Million USD | -924.83% |
| 2000 Q2 | -55.51 Million USD | -391.23% |
| 2000 Q4 | -7.9 Million USD | -53.49% |
| 2000 Q3 | -5.14 Million USD | 90.73% |
| 1999 Q2 | -1.55 Million USD | -4.5% |
| 1999 Q1 | -1.49 Million USD | 0.0% |
| 1999 FY | -7.79 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | -1343.557% |
| Jaguar Health, Inc. | -41.3 Million USD | -1714.932% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -389.939% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -1277.324% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -70.262% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1537.219% |
| ContextLogic Inc. | -317 Million USD | -136.456% |
| MiMedx Group, Inc. | 67.43 Million USD | 1211.474% |
| MEI Pharma, Inc. | 17.77 Million USD | 4316.262% |
| AlloVir, Inc. | -190.41 Million USD | -293.643% |
| Novavax, Inc. | -545.06 Million USD | -37.52% |
| Aptorum Group Limited | -2.82 Million USD | -26436.661% |
| Ardelyx, Inc. | -66.06 Million USD | -1034.556% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -265.153% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -1365.17% |
| Vaxcyte, Inc. | -402.26 Million USD | -86.336% |
| Precigen, Inc. | -95.9 Million USD | -681.581% |
| Pharming Group N.V. | -10.54 Million USD | -7006.248% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -271.824% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2954.097% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2887.394% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -253.203% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -3941.643% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2979.658% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2979.658% |
| Bicycle Therapeutics plc | -180.66 Million USD | -314.896% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -190.72% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -2651.916% |
| Acelyrin, Inc. | -381.64 Million USD | -96.406% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1907.41% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -2098.079% |
| Senti Biosciences, Inc. | -92.91 Million USD | -706.689% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -615.926% |
| AbCellera Biologics Inc. | -146.39 Million USD | -412.006% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -2033.088% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -318.629% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -11112.67% |
| Chimerix, Inc. | -82.09 Million USD | -813.048% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -2452.847% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -3594.086% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1580.519% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -1368.07% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1540.047% |
| Alkermes plc | 355.75 Million USD | 310.696% |
| Fortress Biotech, Inc. | -60.63 Million USD | -1136.154% |
| Fortress Biotech, Inc. | -60.63 Million USD | -1136.154% |
| Agenus Inc. | -245.76 Million USD | -204.998% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -818.812% |
| Dyadic International, Inc. | -6.79 Million USD | -10930.407% |
| ImmuCell Corporation | -5.77 Million USD | -12880.419% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -79981.944% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -563.563% |
| Lantern Pharma Inc. | -15.96 Million USD | -4596.084% |
| Immix Biopharma, Inc. | -15.42 Million USD | -4759.099% |
| Incyte Corporation | 597.59 Million USD | 225.43% |
| IO Biotech, Inc. | -86.08 Million USD | -770.749% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -1185.861% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -3839.101% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -1170.826% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -355.459% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -8717.398% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -921.946% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -100.617% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -30.85% |
| NextCure, Inc. | -62.72 Million USD | -1095.043% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -7406.179% |
| Onconetix, Inc. | -37.4 Million USD | -1903.67% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1798.647% |
| Opthea Limited | -220.24 Million USD | -240.338% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1645.525% |
| PureTech Health plc | -65.69 Million USD | -1040.946% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -915.811% |
| Seer, Inc. | -86.27 Million USD | -768.791% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -5976026.333% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -2207.425% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -5634.201% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -2534.497% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -1203.3% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -1104.027% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -465.741% |
| ChromaDex Corporation | -4.93 Million USD | -15079.567% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -20790.942% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -634.366% |
| CRISPR Therapeutics AG | -153.61 Million USD | -387.968% |
| Precision BioSciences, Inc. | -61.31 Million USD | -1122.406% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -365.778% |
| Innoviva, Inc. | 179.72 Million USD | 517.07% |
| Summit Therapeutics Inc. | -614.92 Million USD | -21.895% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -1018.84% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -1039.766% |
| ESSA Pharma Inc. | -26.58 Million USD | -2719.793% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1931.379% |
| GT Biopharma, Inc. | -7.59 Million USD | -9766.618% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -210.558% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 1149.667% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1425.991% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -7435.044% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -205.205% |
| Aptose Biosciences Inc. | -51.2 Million USD | -1363.798% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -662.546% |
| Soligenix, Inc. | -6.14 Million USD | -12106.48% |
| Century Therapeutics, Inc. | -136.67 Million USD | -448.438% |
| Kura Oncology, Inc. | -152.63 Million USD | -391.097% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -740.152% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -7012.991% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 132656.457% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -131634.095% |
| Autolus Therapeutics plc | -208.38 Million USD | -259.706% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -942.542% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -958.785% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -3359.327% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -232.771% |
| GRI Bio, Inc. | -13.03 Million USD | -5649.536% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -18029.226% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -504.08% |
| IGM Biosciences, Inc. | -246.41 Million USD | -204.188% |
| INmune Bio, Inc. | -30 Million USD | -2397.891% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -577.979% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1676.487% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -4596.047% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -4645.602% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -1155.872% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -640.92% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -171.458% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -215.087% |
| Verastem, Inc. | -87.36 Million USD | -757.952% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -1283.271% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -364.6% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -542.534% |
| Histogen Inc. | -10.62 Million USD | -6957.405% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -5146.586% |
| Surrozen, Inc. | -43.04 Million USD | -1641.478% |
| Organovo Holdings, Inc. | -14.67 Million USD | -5009.175% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -14634.868% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -1332.14% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2867.055% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -2682.564% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -8869.239% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -396.123% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1432.041% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -2421.672% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -7095.127% |
| Apollomics, Inc. | -172.6 Million USD | -334.277% |
| Amarin Corporation plc | -59.11 Million USD | -1168.045% |
| Mesoblast Limited | -87.95 Million USD | -752.207% |
| Turnstone Biologics Corp. | -55.2 Million USD | -1257.911% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -410.041% |
| Synaptogenix, Inc. | -6.03 Million USD | -12313.124% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -4524.673% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -860.737% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -15543.793% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -8821.084% |
| Exelixis, Inc. | 207.76 Million USD | 460.776% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1785.229% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -420.721% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -41.795% |
| NLS Pharmaceutics AG | -12.17 Million USD | -6058.111% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -9516.38% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -2337.696% |
| Gritstone bio, Inc. | -138.49 Million USD | -441.243% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -1062.75% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -18639.409% |
| Avid Bioservices, Inc. | -140.75 Million USD | -432.541% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -4834.768% |
| MediWound Ltd. | -6.71 Million USD | -11060.914% |
| OmniAb, Inc. | -50.61 Million USD | -1380.802% |
| Alector, Inc. | -130.39 Million USD | -474.861% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -559.111% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -1345.729% |
| Zai Lab Limited | -334.62 Million USD | -124.005% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -131.358% |
| Aura Biosciences, Inc. | -76.4 Million USD | -881.006% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -219.465% |
| Immunic, Inc. | -93.61 Million USD | -700.717% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -451.586% |
| Veracyte, Inc. | -74.4 Million USD | -907.428% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -9665.645% |
| FibroGen, Inc. | -284.23 Million USD | -163.717% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2757.453% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -10605.21% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -3880.137% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 280.692% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -3223.285% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1621.315% |
| TG Therapeutics, Inc. | 12.67 Million USD | 6015.144% |
| Galecto, Inc. | -38.34 Million USD | -1854.593% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -3873.11% |
| Fortrea Holdings Inc. | -3.4 Million USD | -21946.088% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -491.869% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -4205.135% |
| XBiotech Inc. | -24.55 Million USD | -2952.356% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -1062.75% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -1095.863% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -661.554% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -3398.236% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -1258.083% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | -23.561% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -998.186% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -1316454.256% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -230.878% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -3266.19% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -241.162% |
| NexImmune, Inc. | -32.34 Million USD | -2217.456% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -14078.691% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -5236.556% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 118.959% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2994.699% |
| Scopus BioPharma Inc. | -11.6 Million USD | -6356.315% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -541.764% |
| Ainos, Inc. | -13.77 Million USD | -5343.262% |
| Pluri Inc. | -20.88 Million USD | -3488.505% |
| Prothena Corporation plc | -147.02 Million USD | -409.812% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -558.26% |
| Celularity Inc. | -196.29 Million USD | -281.857% |
| Rallybio Corporation | -74.56 Million USD | -905.267% |
| Cue Biopharma, Inc. | -50.73 Million USD | -1377.474% |
| MeiraGTx Holdings plc | -84.02 Million USD | -792.055% |
| Omeros Corporation | -117.81 Million USD | -536.235% |
| Humacyte, Inc. | -110.77 Million USD | -576.651% |
| Immunocore Holdings plc | -55.28 Million USD | -1255.774% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -4067.966% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -3168.793% |
| Blueprint Medicines Corporation | -506.98 Million USD | -47.848% |
| CalciMedica, Inc. | -34.35 Million USD | -2081.701% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -1007.598% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -430.085% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -352.121% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -164.626% |
| Pulmatrix, Inc. | -14.12 Million USD | -5208.172% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -2029.754% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -807.049% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -55.773% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -614.751% |
| Cytokinetics, Incorporated | -526.24 Million USD | -42.437% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1978.378% |
| Nutriband Inc. | -5.48 Million USD | -13564.979% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1754.446% |
| Vor Biopharma Inc. | -117.86 Million USD | -535.965% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 117.236% |
| Evogene Ltd. | -23.87 Million USD | -3039.022% |
| ProKidney Corp. | -35.46 Million USD | -2013.361% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -525.875% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -9454.235% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | -16.537% |
| CorMedix Inc. | -46.33 Million USD | -1517.565% |
| BioLineRx Ltd. | -60.61 Million USD | -1136.624% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -636.719% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1725.274% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1763.482% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -829.405% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -892.528% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -156.533% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -2588.933% |
| MediciNova, Inc. | -8.57 Million USD | -8644.859% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -508.035% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -8848.094% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2786.64% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -213.314% |
| Biomea Fusion, Inc. | -117.25 Million USD | -539.262% |
| PTC Therapeutics, Inc. | -626.6 Million USD | -19.624% |
| Mereo BioPharma Group plc | -29.46 Million USD | -2443.837% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -389.395% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -258.028% |
| Absci Corporation | -110.56 Million USD | -577.936% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -2386.126% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -643.345% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -217.698% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 5422.117% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -288.453% |
| Allakos Inc. | -185.7 Million USD | -303.642% |
| Imunon, Inc. | -19.51 Million USD | -3740.983% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -670.09% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 806.206% |
| BioAtla, Inc. | -123.46 Million USD | -507.124% |
| NLS Pharmaceutics AG | -12.17 Million USD | -6058.111% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -4562.066% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -129.04% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1928.653% |
| XOMA Corporation | -40.83 Million USD | -1735.779% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -635.807% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -532.477% |
| aTyr Pharma, Inc. | -50.38 Million USD | -1387.561% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -754.899% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -393.919% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -215.297% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -2034.363% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -9163.131% |
| Akari Therapeutics, Plc | -10 Million USD | -7389.678% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -1113256.108% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 366.187% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -11146.487% |
| UroGen Pharma Ltd. | -102.24 Million USD | -633.116% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -601.888% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -9538.026% |
| Orgenesis Inc. | -55.36 Million USD | -1253.962% |
| Entera Bio Ltd. | -8.88 Million USD | -8332.523% |
| GH Research PLC | -35.58 Million USD | -2006.294% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -3496.771% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -868.583% |
| Xencor, Inc. | -126.08 Million USD | -494.484% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -19805.107% |
| Replimune Group, Inc. | -215.79 Million USD | -247.353% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -3424.631% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 29975.13% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -11146.487% |
| Portage Biotech Inc. | -75.33 Million USD | -894.926% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -8848.094% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -675.508% |
| OncoCyte Corporation | -27.78 Million USD | -2598.128% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -5486.608% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -6639.789% |
| Purple Biotech Ltd. | -19.88 Million USD | -3670.458% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -10579.114% |
| scPharmaceuticals Inc. | -54.81 Million USD | -1267.573% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -4181.737% |
| HilleVax, Inc. | -123.56 Million USD | -506.613% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -7316.315% |
| Tharimmune, Inc. | -9.31 Million USD | -7943.346% |
| Genprex, Inc. | -30.86 Million USD | -2328.891% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -217.714% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -2390.752% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -41963.244% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -14053.415% |
| OKYO Pharma Limited | -16.82 Thousand USD | -4454856.952% |
| Savara Inc. | -54.69 Million USD | -1270.374% |
| Curis, Inc. | -47.41 Million USD | -1480.931% |
| Daré Bioscience, Inc. | -30.16 Million USD | -2385.187% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -4753.11% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -13359.634% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -2414.06% |
| BeiGene, Ltd. | -881.7 Million USD | 14.987% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -3420.085% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -71.774% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -849.36% |
| Erasca, Inc. | -125.04 Million USD | -499.452% |
| bluebird bio, Inc. | -211.91 Million USD | -253.714% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -14889.85% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 547.116% |
| DBV Technologies S.A. | -72.72 Million USD | -930.673% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -14889.85% |
| Moderna, Inc. | -4.71 Billion USD | 84.099% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1766.591% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -13064.155% |
| Molecular Templates, Inc. | -8.12 Million USD | -9126.576% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -1141.252% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -572.867% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -453.791% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1464.238% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -429.995% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -289.568% |
| MacroGenics, Inc. | -9.05 Million USD | -8175.193% |
| RenovoRx, Inc. | -10.23 Million USD | -7225.713% |
| Adicet Bio, Inc. | -142.65 Million USD | -425.429% |
| Prime Medicine, Inc. | -198.13 Million USD | -278.315% |
| Aditxt, Inc. | -32.38 Million USD | -2214.847% |
| Adagene Inc. | -18.94 Million USD | -3856.257% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -10151.578% |
| Quantum-Si incorporated | -95.96 Million USD | -681.124% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -529.735% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -5041.85% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 666.438% |
| SciSparc Ltd. | -5.12 Million USD | -14534.264% |
| Vericel Corporation | -3.18 Million USD | -23456.474% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -623219.806% |
| Minerva Neurosciences, Inc. | -30 Million USD | -2398.111% |
| Generation Bio Co. | -126.61 Million USD | -492.019% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -928.34% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -809.205% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -185.941% |
| Invivyd, Inc. | -198.64 Million USD | -277.344% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -119.189% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -8529.03% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 3386.71% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -7491.321% |
| 2seventy bio, Inc. | -217.57 Million USD | -244.518% |
| ADMA Biologics, Inc. | -28.23 Million USD | -2554.368% |
| Clene Inc. | -49.5 Million USD | -1414.154% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -3263.166% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1416.298% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2786.64% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -128.481% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -2203.319% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 3399.151% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -658.734% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -902.712% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -366.134% |
| Vir Biotechnology, Inc. | -615.06 Million USD | -21.869% |
| Evaxion Biotech A/S | -22.12 Million USD | -3287.873% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -828.417% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -274.656% |
| Trevena, Inc. | -40.28 Million USD | -1760.476% |
| Surrozen, Inc. | -43.04 Million USD | -1641.478% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -984.223% |
| Cingulate Inc. | -23.53 Million USD | -3084.911% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -10744.43% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1780.499% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -9621.162% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -730.913% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -1123.064% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -1159.713% |
| Clearmind Medicine Inc. | -11.95 Million USD | -6169.888% |
| Kronos Bio, Inc. | -112.67 Million USD | -565.259% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -983.236% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -29554277.955% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -772.655% |
| Statera Biopharma, Inc. | -174.4 Million USD | -329.777% |
| ImmunityBio, Inc. | -583.19 Million USD | -28.527% |
| Korro Bio, Inc. | -81.17 Million USD | -823.43% |
| Kineta, Inc. | -14.09 Million USD | -5216.455% |
| BioVie Inc. | -32.12 Million USD | -2233.607% |
| Codexis, Inc. | -76.24 Million USD | -883.168% |
| Celularity Inc. | -196.29 Million USD | -281.857% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -249.401% |
| Celcuity Inc. | -63.77 Million USD | -1075.255% |
| Virax Biolabs Group Limited | -6.73 Million USD | -11031.846% |
| Cibus, Inc. | -267.62 Million USD | -180.079% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1758.769% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1993.119% |
| IN8bio, Inc. | -30 Million USD | -2397.974% |
| Kodiak Sciences Inc. | -260.49 Million USD | -187.752% |
| Annexon, Inc. | -134.23 Million USD | -458.391% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -539.753% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -1124.223% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -2276.259% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -104.64% |
| Eyenovia, Inc. | -27.26 Million USD | -2649.585% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 3571.664% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -140005.981% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -881.057% |
| Arcellx, Inc. | -70.69 Million USD | -960.358% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1708.757% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -460.148% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -2395.479% |
| Moolec Science SA | -51.78 Million USD | -1347.351% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -1331.263% |
| Geron Corporation | -184.12 Million USD | -307.092% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1685.789% |
| Royalty Pharma plc | 1.13 Billion USD | 166.051% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -451.331% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -8329.865% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -3428.498% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -336.632% |
| Humacyte, Inc. | -110.77 Million USD | -576.651% |
| Structure Therapeutics Inc. | -89.62 Million USD | -736.384% |
| 89bio, Inc. | -142.18 Million USD | -427.162% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -986.959% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -7123.35% |
| Genelux Corporation | -28.29 Million USD | -2548.927% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -2478.933% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -323.2% |
| Notable Labs, Ltd. | -11.26 Million USD | -6554.537% |
| Liquidia Corporation | -78.5 Million USD | -854.838% |
| Mustang Bio, Inc. | -51.6 Million USD | -1352.593% |
| Immunovant, Inc. | -259.33 Million USD | -189.033% |
| Quantum-Si incorporated | -95.96 Million USD | -681.124% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -928.932% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -3767.535% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -680.88% |
| Acasti Pharma Inc. | -12.85 Million USD | -5731.845% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -3237.66% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -4596.047% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -310.963% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -17325.643% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -5910.962% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -2441.681% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1822.558% |
| PepGen Inc. | -78.62 Million USD | -853.332% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -2417.945% |
| United Therapeutics Corporation | 984.8 Million USD | 176.114% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -3267.327% |
| Solid Biosciences Inc. | -96.01 Million USD | -680.677% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -15543.793% |
| Immuneering Corporation | -53.47 Million USD | -1301.803% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -14634.868% |
| Silo Pharma, Inc. | -3.7 Million USD | -20154.829% |
| Belite Bio, Inc | -31.63 Million USD | -2269.648% |
| XOMA Corporation | -40.83 Million USD | -1735.779% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -1278.768% |
| Bionomics Limited | -15.49 Billion USD | 95.162% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -792.501% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2470.796% |
| uniQure N.V. | -308.47 Million USD | -142.989% |
| Cassava Sciences, Inc. | -97.21 Million USD | -671.025% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -10151.578% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -507.281% |
| Forte Biosciences, Inc. | -31.47 Million USD | -2281.392% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -9039.163% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -2478.667% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -140005.981% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2757.453% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -4446.964% |
| Altimmune, Inc. | -88.44 Million USD | -747.476% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -394.49% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2470.796% |
| Compugen Ltd. | -18.75 Million USD | -3896.838% |
| Peak Bio, Inc. | -1259.26 USD | -59524303.221% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1527.76% |
| Benitec Biopharma Inc. | -21.75 Million USD | -3346.127% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -121.248% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -803.594% |
| Zura Bio Limited | -60.36 Million USD | -1141.827% |
| PolyPid Ltd. | -23.86 Million USD | -3040.863% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -4664.601% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -803.594% |
| Instil Bio, Inc. | -156.08 Million USD | -380.224% |
| argenx SE | -295.05 Million USD | -154.045% |
| Immunome, Inc. | -106.8 Million USD | -601.802% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1663.936% |
| Verona Pharma plc | -54.36 Million USD | -1278.666% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -650.19% |
| Shattuck Labs, Inc. | -87.29 Million USD | -758.63% |
| CervoMed Inc. | -2.17 Million USD | -34412.469% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -501.333% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -5529.07% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1620.967% |
| Moolec Science SA | -51.78 Million USD | -1347.351% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -4334729.424% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -454.753% |
| AnaptysBio, Inc. | -163.61 Million USD | -358.117% |
| Design Therapeutics, Inc. | -66.86 Million USD | -1021.066% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -820.686% |
| NeurAxis, Inc. | -14.62 Million USD | -5024.655% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1878.689% |
| Lumos Pharma, Inc. | -34.03 Million USD | -2102.406% |
| Achilles Therapeutics plc | -69.66 Million USD | -975.959% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -650.19% |
| 180 Life Sciences Corp. | -19.93 Million USD | -3660.034% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 25012.573% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -29554277.955% |
| Nutriband Inc. | -5.48 Million USD | -13564.979% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -644.379% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1442.097% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -872.315% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -2106.556% |
| MoonLake Immunotherapeutics | -36 Million USD | -1981.711% |
| Palisade Bio, Inc. | -12.3 Million USD | -5994.041% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1679.43% |
| Beam Therapeutics Inc. | -132.52 Million USD | -465.596% |
| Neurogene Inc. | -36.31 Million USD | -1963.956% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -358.689% |
| AEON Biopharma, Inc. | -52.55 Million USD | -1326.225% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -663.719% |
| Sesen Bio, Inc. | -19.88 Million USD | -3669.699% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -947.115% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -5889.877% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -68.807% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -571.86% |
| Athira Pharma, Inc. | -117.67 Million USD | -536.997% |
| Vaccinex, Inc. | -20.25 Million USD | -3601.383% |
| HCW Biologics Inc. | -24.99 Million USD | -2898.955% |
| XOMA Corporation | -40.83 Million USD | -1735.779% |
| Nektar Therapeutics | -276.05 Million USD | -171.527% |
| Arvinas, Inc. | -367.3 Million USD | -104.075% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -1113256.108% |
| Merus N.V. | -154.93 Million USD | -383.782% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -669.355% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -2288.297% |
| Rezolute, Inc. | -68.45 Million USD | -994.914% |
| Clene Inc. | -49.5 Million USD | -1414.154% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -4759.911% |
| BeyondSpring Inc. | -21.02 Million USD | -3464.953% |
| Synlogic, Inc. | -57.28 Million USD | -1208.556% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -6198.353% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -6823.767% |
| Peak Bio, Inc. | -1259.26 USD | -59524303.221% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1905.906% |
| Krystal Biotech, Inc. | 10.93 Million USD | 6956.632% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -423.81% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -130.562% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -16128.029% |
| MannKind Corporation | -11.93 Million USD | -6178.832% |
| Ikena Oncology, Inc. | -68.16 Million USD | -999.62% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -3466.819% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -706.567% |
| Gossamer Bio, Inc. | -179.81 Million USD | -316.85% |
| CohBar, Inc. | -11.96 Million USD | -6166.172% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -2806.65% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -2386.126% |
| Legend Biotech Corporation | -518.25 Million USD | -44.633% |
| Mural Oncology plc | -207.44 Million USD | -261.329% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -503.929% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -3998.296% |
| Disc Medicine, Inc. | -76.42 Million USD | -880.736% |
| Champions Oncology, Inc. | -7.27 Million USD | -10201.91% |
| REGENXBIO Inc. | -263.49 Million USD | -184.472% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -6962.676% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1477.87% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1873.402% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -648.347% |
| Vaxart, Inc. | -82.46 Million USD | -808.952% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 224680.616% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1896.582% |
| Cellectis S.A. | -101.05 Million USD | -641.712% |
| Longeveron Inc. | -21.41 Million USD | -3400.523% |
| Repare Therapeutics Inc. | -93.79 Million USD | -699.146% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -39.851% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -953.221% |
| Revolution Medicines, Inc. | -436.36 Million USD | -71.774% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -11307.198% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -2331.764% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -981.111% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -1057.954% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -7540.067% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 120.709% |
| Denali Therapeutics Inc. | -145.22 Million USD | -416.145% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -623219.806% |
| Veru Inc. | -93.15 Million USD | -704.665% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -2673.195% |
| Cingulate Inc. | -23.53 Million USD | -3084.911% |
| Passage Bio, Inc. | -102.06 Million USD | -634.423% |
| Context Therapeutics Inc. | -23.96 Million USD | -3027.86% |
| Exicure, Inc. | -16.91 Million USD | -4331.637% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -296.771% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1884.872% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -11418.82% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -305.878% |
| Nuvalent, Inc. | -126.21 Million USD | -493.862% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -7028.105% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -762.771% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -2354.056% |
| OmniAb, Inc. | -50.61 Million USD | -1380.802% |
| Anew Medical, Inc. | 1.34 Million USD | 55783.313% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -4571.655% |
| Lipocine Inc. | -16.35 Million USD | -4483.924% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -1028.968% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -1077.176% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1676.487% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1462.672% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -3679.774% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -38.427% |
| Ocugen, Inc. | -63.07 Million USD | -1088.318% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -682.985% |
| Q32 Bio Inc. | -112.96 Million USD | -563.563% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -4259.976% |
| Alumis Inc. Common Stock | -154.99 Million USD | -383.613% |
| Equillium, Inc. | -13.33 Million USD | -5521.05% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -1141.704% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -9283.856% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -3876.224% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -1168.689% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -554.489% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -3978.621% |
| Dominari Holdings Inc. | -22.88 Million USD | -3175.793% |
| Edesa Biotech, Inc. | -8.37 Million USD | -8850.679% |
| vTv Therapeutics Inc. | -20.25 Million USD | -3601.565% |
| Bio-Techne Corporation | 168.1 Million USD | 545.892% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -112.892% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 681.723% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -515.246% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1875.716% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -565.442% |
| Nkarta, Inc. | -117.5 Million USD | -537.924% |
| BioCardia, Inc. | -11.57 Million USD | -6377.979% |
| Iterum Therapeutics plc | -38.37 Million USD | -1853.473% |